Ali Rizvi to Proprotein Convertase 9
This is a "connection" page, showing publications Ali Rizvi has written about Proprotein Convertase 9.
Connection Strength
0.194
-
Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia. Expert Opin Drug Saf. 2022 Jan; 21(1):9-20.
Score: 0.194
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.